-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Pp3aDhMmksXu2ujNeeqesW8PXN0W7iF8gBxIedA7GIR2tys8IQlulftu1a1h1rhE J2WTHVqMlVEuRibbXqU38w== 0001455244-10-000093.txt : 20100407 0001455244-10-000093.hdr.sgml : 20100407 20100407181742 ACCESSION NUMBER: 0001455244-10-000093 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100405 FILED AS OF DATE: 20100407 DATE AS OF CHANGE: 20100407 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kessler Paul D. CENTRAL INDEX KEY: 0001428524 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-04829 FILM NUMBER: 10738138 MAIL ADDRESS: STREET 1: C/O NABI BIOPHARMACEUTICALS STREET 2: 12276 WILKINS AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20852 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NABI BIOPHARMACEUTICALS CENTRAL INDEX KEY: 0000072444 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 591212264 STATE OF INCORPORATION: DE FISCAL YEAR END: 1225 BUSINESS ADDRESS: STREET 1: 5800 PARK OF COMMERCE BLVD N W STREET 2: STE 322 CITY: BOCA RATON STATE: FL ZIP: 33487 BUSINESS PHONE: 5619895800 MAIL ADDRESS: STREET 1: 5800 PARK OF COMMERCE BLVD NW STREET 2: STE 322 CITY: BOCA RATON STATE: FL ZIP: 33487 FORMER COMPANY: FORMER CONFORMED NAME: NABI /DE/ DATE OF NAME CHANGE: 19960405 FORMER COMPANY: FORMER CONFORMED NAME: NORTH AMERICAN BIOLOGICALS INC DATE OF NAME CHANGE: 19920703 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2010-04-05 0000072444 NABI BIOPHARMACEUTICALS NABI 0001428524 Kessler Paul D. C/O NABI BIOPHARMACEUTICALS 12276 WILKINS AVE ROCKVILLE MD 20852 0 1 0 0 SVP Clinical, Med. & Reg.; CMO Common Stock 2010-04-05 4 S 0 200 5.30 D 118300 D Common Stock 2010-04-05 4 S 0 928 5.31 D 117372 D Common Stock 2010-04-05 4 S 0 1520 5.32 D 115852 D Common Stock 2010-04-05 4 S 0 700 5.34 D 115152 D Common Stock 2010-04-05 4 S 0 200 5.36 D 114952 D Common Stock 2010-04-05 4 S 0 500 5.37 D 114452 D Common Stock 2010-04-05 4 S 0 600 5.38 D 113852 D Common Stock 2010-04-05 4 S 0 600 5.39 D 113252 D The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. This disposition was made to fund the Reporting Person's tax obligation arising from the vesting of restricted stock. James E. Dawson, as attorney-in-fact 2010-04-07 -----END PRIVACY-ENHANCED MESSAGE-----